Extensión de la pandemia Covid-19 frente al acceso a la vacuna y las capacidades tecnológicas y de innovación del sector biofarmacéutico de México

Abstract

The aim of this paper is to analyze the spread of COVID-19 global evolution and its effects in Mexico, through the empirical evidence available so far. In a context of global vaccines in development, biopharmaceutical local firms technologically dependent on multinational companies and a weak Mexican health system, we carry out pandemic extension simulations.  We corroborate that without the existence of vaccines, the SARS-COV-2 virus, source of the COVID-19, will probably remain in Mexico until mid-2022. By considering the emergency of creating an effective vaccine to immunize the population of this pandemic, we estimate the technological absorption capacities of the Mexican biopharmaceutical sector; through a Poisson regression model proposed, using USPTO patents data, we identify factors having influence in such capabilities: technological knowledge stock, team research size, academic science -technology links and patent value cited. The findings allow us to propose policies to foster biopharmaceutical innovation with favorable impact in health population